CT-Gross Tumor Volume Predicts Outcome in Larynx Preservation

This article originally appeared here.
Share this content:
CT-Gross Tumor Volume Predicts Outcome in Larynx Preservation
CT-Gross Tumor Volume Predicts Outcome in Larynx Preservation

THURSDAY, May 5, 2016 (HealthDay News) -- For patients undergoing larynx preservation, pretreatment computed tomography-gross tumor volume (CT-GTV) is predicative of an increase in time with tracheostomy and percutaneous endoscopic gastrostomy (PEG), according to a study published online April 30 in Head & Neck.

Newton J. Hurst Jr., M.D., Ph.D., from Wayne State University in Detroit, and colleagues examined the predictive value of pretreatment GTV for persistence of tracheostomy and PEG tube in larynx preservation patients. Before initiation of therapy, 75 patients underwent CT and the GTV was contoured. GTV information was available for 41 patients.

The researchers found that threshold GTVs of 27.16 cc and 12 cc were identified for association of time with a tracheostomy and PEG tube, respectively, using recursive partitioning analysis. For time with tracheostomy, the median times above and below these thresholds were 1.84 and 0.75 years, respectively (P = 0.03); the corresponding values were 1.75 and 0.84 years for time with PEG tube (P = 0.10).

"We demonstrate here that pretreatment CT-GTV is predictive of an approximately 2.5-fold and approximately 2-fold, respectively, increase in length of time with a tracheostomy and a PEG tube -- two surrogates for poor functional outcomes and reduced quality of life," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »